greeksoup/ stock research
Stock research / United States / GMAB / Year to 31 December 2023

Genmab A/S (GMAB) annual results, year to 31 December 2023: revenue USD 2,390 million, from the 20-F

Genmab A/S files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2023 it reported revenue of USD 2,390 million. Its profit was USD 631 million, and diluted earnings per share USD 9.58.

Revenue
USD 2,390 million
FY2023FY2023
Operating margin
32.3%
FY2023FY2023
Net income
USD 631 million
FY2023FY2023
Diluted EPS
USD 9.58
FY2023FY2023

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2023
Revenue2,390
Cost of sales33.0
Research and development1,107
Selling, general and administrative478
Operating profit772
Finance costs254
Profit before tax817
Income tax186
Profit for the year631
Profit attributable to shareholders631
Filing20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2023
Diluted EPS9.58
Basic EPS9.67
Filing20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2023
Cash from operations1,071
Purchase of property, plant and equipment53.0
Free cash flow1,018
Cash from investing-185
Cash from financing-89.0
Filing20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2023
Funded by
Equity attributable to shareholders4,687
Borrowings, as filed0.0
Lease liabilities114
Other liabilities431
Total equity and liabilities5,232
Owned
Property, plant and equipment142
Goodwill0.0
Other intangible assets15.0
Cash and cash equivalents2,204
Trade and other receivables733
Inventories8.0
Other assets2,130
Total assets5,232
Filing20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2023
Operating margin32.3%
Net margin26.4%
Free cash flow margin42.6%
Return on year-end equity13.5%
Effective tax rate22.8%
Filing20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2023, filed 17 February 2026: the filing. The figures are in US dollars as filed.